Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20141
20161
20172
20182
20193
20203
20214
20222
20235
20244
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18
Active, not recruiting7
Completed7
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Eli Lilly and Company2
GlaxoSmithKline2
AmMax Bio, Inc.1
Aminex Therapeutics, Inc.1
Anbogen Therapeutics, Inc.1
Array BioPharma1
AstraZeneca1
BeiGene1
Betta Pharmaceuticals Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms39
Carcinoma, Non-Small-Cell Lung20
Endometrial Neoplasms13
Ovarian Neoplasms13
Neoplasm Metastasis10
Pancreatic Neoplasms9
Stomach Neoplasms9
Lung Neoplasms8
Melanoma7
Biliary Tract Neoplasms6

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.